logo
Plus   Neg
Share
Email

Hochschild Mining Q1 Production Declines; Affirms 2019 Outlook - Quick Facts

Hochschild Mining PLC (HOC.L) on Tuesday reported a decline in production in the first quarter of 2019 compared to the year-ago period, but affirmed its production and cost targets for fiscal 2019.

In the first quarter of 2019, the company delivered attributable production result of 9.83 million silver equivalent ounces, or 121,367 gold equivalent ounces. The production results reflect a strong contribution from Inmaculada and increased first-quarter output from Pallancata.

This compared to attributable production of 10.3 million silver equivalent ounces, or 126,590 gold equivalent ounces in the year-ago period.

Looking ahead, the company said it is on track to meet its stated production and cost targets for 2019.

The company said it is on track to deliver its overall 2019 production target of 457,000 gold equivalent ounces, or 37.0 million silver equivalent ounces.

The company also said that its all-in sustaining costs for 2019 are on track to meet its guidance of $960 to $1,000 per gold equivalent ounce, or $11.8 to $12.3 per silver equivalent ounce.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
Follow RTT